Read more

September 11, 2021
1 min read
Save

Cequa, timolol and new lens technologies top recent blog posts

Recent blogs on Healio/OSN include an explanation of patient payments for Cequa and a look at timolol in glaucoma treatment.

Read these and other popular blogs below.

BLOG: Game on: Cequa jumps into Medicare Part D

Ladies and gentlemen, we have ourselves a contest here! It’s game on for immunomodulators in the Medicare Part D space. Read more.

BLOG: Adjunctive medical therapy for glaucoma: The case against timolol

We are extremely fortunate to have a number of efficacious and relatively safe medical therapies to choose from when treating our patients with ocular hypertension and glaucoma. Read more.

BLOG: First impression of Tecnis Synergy

Recently, I had the opportunity to begin implanting Tecnis Synergy and Tecnis Synergy Toric IOLs (Johnson & Johnson Vision) in my practice, which is heavily focused on refractive lens surgery with presbyopia-correcting IOLs. Read more.

BLOG: Himalayan Cataract Project in Ethiopia

Imagine doing something 80 to 100 times a day, the same thing again and again, all day long. Now imagine if that something is cataract surgery. Read more.

BLOG: A presbyopia-correcting lens for nearly every eye

For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that came with all of them is that they can only be used safely in eyes with near-perfect visual potential. Read more.